(210) | Number of the EPO application | 20164728 |
(220) | Filing date of the EPO application | 2016.10.21 |
(80) | EPO patent specification publication (B) | EPB nr. 17/2022, 2022.04.27 |
(110) | EPO patent number | 3718565 |
(11) | Number of the document | MD 3718565 T2 |
(21) | Number of the application | e 2021 0275 |
(71) | Name(s) of applicant(s), code of the country | ModernaTX, Inc., US; |
(72) | Name(s) of inventor(s), code of the country | CIARAMELLA Giuseppe, US; HIMANSU Sunny, US; |
(73) | Name(s) of owner(s), code of the country | ModernaTX, Inc., US; |
(54) | Title of the invention | Respiratory virus vaccines |
(13) | Kind-of-document code | T2 |
(51) | International Patent Classification | A61K 39/12 (2006.01.01); A61P 11/00 (2006.01.01); C07K 16/10 (2006.01.01) |
(19) | Country | US |
(41) | Date of publication of the application | 2021.04.30 |
(49) | Date of publication of the translation of the validated European patent specification | 2022.09.30 |
(30) | Priority | 201562245031 P, 2015.10.22, US; 201562244813 P, 2015.10.22, US; 201562244946 P, 2015.10.22, US; 201562244802 P, 2015.10.22, US; 201562244837 P, 2015.10.22, US; 201562247362 P, 2015.10.28, US; 201562247483 P, 2015.10.28, US; 201562247394 P, 2015.10.28, US; 201562247297 P, 2015.10.28, US |
(74) | Patent attorney | (Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova |